Skip to main content

Table 1 Patient characteristics and days postburn from admission to begin and end of the study periods

From: IGF-I/IGFBP-3 Equilibrates Ratios of Pro- to Anti-inflammatory Cytokines, Which Are Predictors for Organ Function in Severely Burned Pediatric Patients

 

Control n = 7

IGF-I/BP-3 n = 17

Age (yrs)

5.7 ± 1.1

6.2 ± 0.8

Gender (F/M)

4/3

10/7

Body weight (kg)

25 ± 3

27 ± 4

Height (cm)

109 ± 11

118 ± 6

TBSA-burn (%)

59 ± 4

55 ± 4

3rd degree-burn (%)

46 ± 6

46 ± 6

Mortality (%)

17

0

Study periods

  

Hospital admission (days postburn)

7 ± 2

7 ± 3

Start of study period I (days postburn)

12 ± 3

14 ± 3

End of study period I (days postburn)

17 ± 3

19 ± 3

Start of study period II (days postburn)

24 ± 4

28 ± 3

End of study period II (days postburn)

29 ± 4

33 ± 3

  1. Data presented as means ± SEM. TBSA = total body surface area.